国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (23): 3462-3466.DOI: 10.3760/cma.j.issn.1007-1245.2023.23.031

• 护理研究 • 上一篇    下一篇

J-Valve介入瓣膜用于不同瓣位生物瓣衰败瓣中瓣治疗的术中护理

宋海娟  谢庆  陈晓霞  刘小民  郭海江  庄建   

  1. 广东省人民医院心外手术室,广州 510080

  • 收稿日期:2023-03-17 出版日期:2023-12-01 发布日期:2024-01-04
  • 通讯作者: 郭海江,Email:guohj1988@163.com
  • 基金资助:

    广东省登峰计划项目(DFJH201802);广东省科研机构创新能力建设稳定支持项目(2022YFC2407406、KD022022015);广州市科技计划项目(202206010049、2023A04J0487)

Intraoperative care of valve-in-valve implantation treatment with J-Valve interventional valve for biovalvular decay in different valve positions

Song Haijuan, Xie Qing, Chen Xiaoxia, Liu Xiaomin, Guo Haijiang, Zhuang Jian   

  1. Heart Surgery Operating Room, Guangdong Provincial People's Hospital, Guangzhou 510080, China

  • Received:2023-03-17 Online:2023-12-01 Published:2024-01-04
  • Contact: Guo Haijiang, Email: guohj1988@163.com
  • Supported by:

    Guangdong Peak Project (DFJH201802); 2022 Stability Support for Innovative Capacity Building of Guangdong Provincial Scientific Research Institutions (2022YFC2407406, KD022022015); Guangzhou Science and Technology Plan Project (202206010049, 2023A04J0487)

摘要:

目的 总结J-Valve介入瓣膜行瓣中瓣治疗在不同瓣位外科生物瓣衰败患者中的早期结果及术中护理经验。方法 选取2020年4月至2021年8月期间,在广东省人民医院因不同瓣位外科生物瓣衰败行介入瓣中瓣手术的39例患者作为研究对象,其中19例男性,20例女性,年龄(72.6±10.8)岁,全部采用J-Valve介入瓣膜治疗。实施有针对性的术中护理方案,加强病情监测、安全护理、手术护理配合,采取有效护理干预紧急应对术中并发症。观察患者术后重症监护室治疗时间、术后住院时间,术后有无发生脑卒中、植入永久起搏器、心包积液等并发症,住院期间护理满意度。结果 35例单纯行经导管二尖瓣瓣中瓣植入术的患者手术中无死亡,1例因介入瓣膜移位至左心室而紧急中转开胸,1例因心包填塞再次开胸止血,1例出现轻度左心室流出道梗阻;除1例术后30 d内因颅内出血行开颅手术外,无患者出现脑卒中、植入永久起搏器、心包积液及因心源性疾病再入院并发症。其余4例非单纯经导管二尖瓣瓣中瓣植入术的患者中,1例经心尖主动脉瓣瓣中瓣植入术及1例经右心房三尖瓣瓣中瓣植入术的患者均顺利完成手术,无术中及术后并发症;1例经心尖同期行二尖瓣瓣中瓣植入术及主动脉瓣瓣中瓣植入术的患者,在术后16 d因严重肺出血及多脏器功能衰竭死亡;1例经心尖同期行二尖瓣瓣中瓣植入术联合经导管主动脉瓣置换术及二尖瓣瓣周漏封堵术的患者,在术后10 d因肺部真菌感染致感染性休克死亡。住院期间护理满意度调查问卷统计结果均为满意。结论 在生物瓣衰败的高危患者中采用J-Valve介入瓣膜行二尖瓣瓣中瓣植入术取得良好的早期临床效果,也可安全应用于主动脉瓣或三尖瓣位生物瓣衰败的瓣中瓣治疗,为不同瓣位生物瓣衰败患者提供了一种可替代外科手术的新选择,但在同一时期进行多瓣位介入手术时仍需非常慎重。在手术治疗过程中,实施有科学依据的护理方案,可有效预防并发症,促进早期康复,提高护理满意度。

关键词:

心脏瓣膜置换术, J-Valve, 生物瓣衰败, 经导管瓣中瓣治疗, 术中护理

Abstract:

Objective To summarize the early results and intraoperative nursing experiences of valve-in-valve implantation treatment with J-Valve interventional valve in patients with biovalvular decay in different valve positions. Methods From April 2020 to August 2021, 39 patients who underwent valve-in-valve implantation treatment due to the decay of surgical biological valves in different valve positions in Guangdong Provincial People's Hospital were selected as the research subjects, including 19 males and 20 females, with an age of (72.6±10.8) years old, all of whom were treated with J-Valve interventional valve. Targeted intraoperative nursing plans were implemented, condition monitoring, safety nursing, and surgical nursing cooperation were strengthened, and effective nursing interventions were taken to urgently respond to intraoperative complications. The duration of treatment in intensive care unit (ICU) and hospital stay, postoperative complications such as stroke, permanent pacemaker implantation, and pericardial effusion, and nursing satisfaction during hospitalization were observed. Results There were no deaths during surgery in 35 patients who underwent transcatheter mitral valve-in-valve implantation alone, 1 case had emergency thoracotomy due to interventional valve displacement to the left ventricle, 1 case had chest reopening to stop bleeding due to cardiac tamponade, and 1 case had mild left ventricular outflow tract obstruction. Except for 1 case who underwent craniotomy due to intracranial hemorrhage within 30 days after surgery, no cases developed complications of stroke, permanent pacemaker implantation, pericardial effusion, and readmission due to cardiogenic disease. Among the remaining 4 cases who did not have transcatheter mitral valve-in-valve implantation alone, 1 case with transapical aortic valve-in-valve implantation and 1 case with transatrial tricuspid valve-in-valve implantation successfully completed surgical treatment without intraoperative and postoperative complications. One case who underwent transapical mitral-aortic valve-in-valve implantation died of severe pulmonary hemorrhage and multi-organ failure 16 days after surgery. One case who underwent transapical mitral valve-in-valve implantation + transcatheter aortic valve replacement + mitral perivalvular leakage closure died of septic shock caused by fungal infection in the lungs 10 days after surgery. The statistical results of nursing satisfaction questionnaire during hospitalization were satisfactory. Conclusions Mitral valve-in-valve implantation treatment with J-Valve interventional valve in high-risk patients with biovalvular decay has achieved good early clinical results, and can also be safely applied in the treatment of intravalvular valves with aortic or tricuspid valve decay, providing a new alternative to surgery for patients with biovalvular decay in different valve positions, but it is still necessary to be very cautious when performing multi-valve interventional surgery during the same period. In the process of surgical treatment, the implementation of scientifically based nursing plans can effectively prevent the complications, promote the early recovery, and improve the nursing satisfaction.

Key words:

Heart valve replacement, J-Valve, Biovalvular decay, Transcatheter valve-in-valve implantation, Intraoperative care